Align Technology (NASDAQ:ALGN) Issues Quarterly Earnings Results

Align Technology (NASDAQ:ALGN) posted its quarterly earnings data on Wednesday. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.26 by $0.32, FiscalAI reports. The business had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.02 billion. Align Technology had a net margin of 10.50% and a return on equity of 16.00%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same period last year, the firm posted $2.13 earnings per share.

Here are the key takeaways from Align Technology’s conference call:

• Better-than-expected Q1: Revenues were $1.04B (up 6.2% YoY), clear aligner shipments hit a record 686,000 cases, and non-GAAP gross margin expanded, reflecting operational efficiencies and higher ASPs.
• Broad international and channel momentum: Double-digit volume growth in EMEA, APAC and Latin America, DSOs accounted for ~25% of volumes, iTero active scanner base exceeded 125,000 with over 12M scans in Q1.
• Capital returns and guidance reaffirmed: Management reaffirmed full?year 2026 guidance (3%–4% revenue growth, mid-single?digit aligner volume growth) and announced up to $200M more in share repurchases, with $800M still available under the program.
• Near-term demand risks and North America softness: North America showed a modest YoY decline, and management baked prudence into Q2 guidance citing potential patient?traffic, consumer and freight impacts from the Middle East conflict and adverse FX.
• Cost and revenue-timing headwinds: Operating expenses rose 8.3% YoY driven by legal settlement costs and higher compensation, and deferred revenue declined as the product mix shifts toward zero?AA configurations that accelerate recognition (improving cash conversion but reducing future deferral-based revenue).

Align Technology Trading Up 0.9%

Align Technology stock traded up $1.53 during midday trading on Friday, hitting $177.54. 162,784 shares of the stock were exchanged, compared to its average volume of 1,196,223. Align Technology has a fifty-two week low of $122.00 and a fifty-two week high of $208.30. The stock has a market capitalization of $12.72 billion, a price-to-earnings ratio of 29.63, a PEG ratio of 1.94 and a beta of 1.81. The stock’s 50-day simple moving average is $179.02 and its 200 day simple moving average is $164.00.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Robert W. Baird set a $218.00 target price on shares of Align Technology in a research report on Thursday, February 5th. Mizuho increased their target price on shares of Align Technology from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. UBS Group increased their target price on shares of Align Technology from $175.00 to $185.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. Wells Fargo & Company increased their target price on shares of Align Technology from $181.00 to $200.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Finally, Leerink Partners increased their target price on shares of Align Technology from $225.00 to $230.00 in a research report on Thursday. Eight equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $205.85.

Align Technology announced that its board has initiated a stock buyback program on Wednesday, April 29th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to purchase up to 1.6% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.

Align Technology News Summary

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q1 results beat expectations — Align reported $2.58 EPS vs. $2.26 expected and $1.04B revenue (beats), driven by record Invisalign shipments, rising margins and steady global demand; management reiterated fiscal?2026 guidance. Align Technology Announces First-Quarter 2026 Financial Results
• Positive Sentiment: $200M share repurchase — the Board authorized a $200M buyback (?1.6% of shares outstanding), a shareholder?friendly move that can support the stock and signal management confidence in intrinsic value. Align Technology announces $200M share repurchase
• Positive Sentiment: Analyst price?target increases — Evercore raised its target to $220 and Leerink (SVB Leerink) to $230, both implying ~24–30% upside from recent levels, reinforcing bullish sentiment among institutional analysts. Evercore raises ALGN price target to $220 Leerink raises ALGN price target to $230
• Neutral Sentiment: Product and innovation visibility — Align previewed 2026 product and digital?orthodontics developments at the AAO conference, which supports medium?term demand and competitive positioning but is less likely to move near?term trading. Align Technology showcases advances at AAO
• Neutral Sentiment: Earnings call commentary — transcripts and highlights emphasize global aligner momentum and operational execution; useful for validating the beat but largely confirmatory following the release. Earnings call highlights
• Negative Sentiment: Q2 revenue cadence caution — management gave Q2 revenue guidance in a $1.0B–$1.1B range that sits near the lower end of Street expectations, which could temper upside if investors focus on near?term sequential softness. Q1 results and Q2 guidance summary

Insider Transactions at Align Technology

In other Align Technology news, EVP John Morici sold 7,969 shares of Align Technology stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $189.31, for a total transaction of $1,508,611.39. Following the completion of the sale, the executive vice president directly owned 8,237 shares in the company, valued at $1,559,346.47. This trade represents a 49.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.75% of the company’s stock.

Institutional Investors Weigh In On Align Technology

A number of institutional investors have recently made changes to their positions in the stock. Sunbelt Securities Inc. increased its position in shares of Align Technology by 222.4% during the fourth quarter. Sunbelt Securities Inc. now owns 158 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 109 shares during the last quarter. Kovitz Investment Group Partners LLC increased its position in shares of Align Technology by 37.1% during the fourth quarter. Kovitz Investment Group Partners LLC now owns 6,905 shares of the medical equipment provider’s stock valued at $1,078,000 after acquiring an additional 1,867 shares during the last quarter. Compound Planning Inc. acquired a new stake in shares of Align Technology during the fourth quarter valued at about $228,000. Corient Private Wealth LLC increased its position in shares of Align Technology by 1.3% during the fourth quarter. Corient Private Wealth LLC now owns 15,473 shares of the medical equipment provider’s stock valued at $2,246,000 after acquiring an additional 192 shares during the last quarter. Finally, Alberta Investment Management Corp acquired a new stake in shares of Align Technology during the fourth quarter valued at about $1,530,000. 88.43% of the stock is currently owned by institutional investors and hedge funds.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.